Similar articles

• [Uptake of technetium-99m pyrophosphate in cardiac amyloidosis].

  Montes J, López L, Martín F, Pinedo JI, Galván R, Ortiz Berrocal J. Montes J, et al. Rev Esp Cardiol. 1985 Jul-Aug;38(4):300. Rev Esp Cardiol. 1985. PMID: 2996085 Spanish. No abstract available.
• Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85 years and older.

  Goldstein SA, Lindsay J Jr, Chandeysson PL, Nolan NG. Goldstein SA, et al. Am J Cardiol. 1989 Mar 15;63(11):752-3. doi: 10.1016/0002-9149(89)90267-1. Am J Cardiol. 1989. PMID: 2538049 No abstract available.
• Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.

  Gertz MA, Brown ML, Hauser MF, Kyle RA. Gertz MA, et al. Arch Intern Med. 1987 Jun;147(6):1039-44. Arch Intern Med. 1987. PMID: 3036031
• Radiopharmaceutical supply disruptions and the use of ^99mTc-hydroxymethylene diphosphonate as an alternative to ^99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement.

  Miller EJ, Campisi R, Shah NR, McMahon S, Cuddy S, Gallegos-Kattan C, Maurer MS, Damy T, Slart RHJA, Bhatia K, Einstein AJ. Miller EJ, et al. J Nucl Cardiol. 2022 Oct;29(5):2748-2760. doi: 10.1007/s12350-022-03059-5. Epub 2022 Jul 15. J Nucl Cardiol. 2022. PMID: 35838892 Free PMC article. Review. No abstract available.
• [Value of myocardial scintigraphy with 99m Tc-pyrophosphate in the diagnosis of ischemic heart disease].

  Botnar' VI, Dvoskina IS. Botnar' VI, et al. Med Radiol (Mosk). 1983 Oct;28(10):53-8. Med Radiol (Mosk). 1983. PMID: 6314083 Review. Russian. No abstract available.